Legal Opinion from Beijing Zhonglun (Shenzhen) Law Firm on Shenzhen Kaili Biomedical Technology Co., Ltd.'s First Extraordinary Shareholders' Meeting in 2026
To: Shenzhen Kaili Biomedical Technology Co., Ltd.
Beijing Zhonglun (Shenzhen) Law Firm (hereinafter referred to as "this Firm") has been entrusted by Shenzhen Kaili Biomedical Technology Co., Ltd. (hereinafter referred to as "the Company") to appoint lawyers to attend the Company's first extraordinary shareholders' meeting in 2026 (hereinafter referred to as "this Shareholders' Meeting") and to provide legal opinions on matters such as the convening and holding procedures of this Shareholders' Meeting, the qualifications of attendees, voting procedures, and voting results.
The lawyers of this Firm participated in the on-site meeting of this Shareholders' Meeting in accordance with the requirements of the "Rules for Shareholders' Meetings of Listed Companies" (hereinafter referred to as "the Shareholders' Meeting Rules") and conducted verification of relevant documents and facts provided by the Company. The following legal opinions are hereby issued:
I. On the Convening, Notification, and Holding Procedures of this Shareholders' Meeting
(1) The Convener of this Shareholders' Meeting
The convener of this Shareholders' Meeting is the Company's board of directors. The lawyers of this Firm believe that the board of directors is qualified to convene this Shareholders' Meeting.
(2) Notification of this Shareholders' Meeting
The Company's board of directors published the notice of the first extraordinary shareholders' meeting in 2026 on March 18, 2026, on the designated information disclosure website (http://www.cninfo.com.cn), notifying the convening of this Shareholders' Meeting. The announcement specified the time, place, agenda, method of holding the meeting, attendees, and registration matters. The Company has disclosed the content of the proposals in accordance with relevant regulations. The lawyers of this Firm believe that the notification of this Shareholders' Meeting complies with the provisions of the Company Law, the Shareholders' Meeting Rules, and other relevant laws, regulations, and normative documents, as well as the Company's Articles of Association.
(3) Holding of this Shareholders' Meeting
This Shareholders' Meeting was held in a combination of on-site voting and online voting. The on-site meeting took place on April 3, 2026, at 14:30 in Meeting Room 121, 1st Floor, Kaili Medical Building, No. 368, Optoelectronic North Road, Guangming District, Shenzhen. The online voting through the Shenzhen Stock Exchange trading system was available from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on April 3, 2026; the specific time for internet voting was from 9:15 to 15:00 on the same day. The lawyers of this Firm believe that the time, place, and content of the meeting are consistent with the relevant content specified in the notice and comply with the provisions of the Company Law, the Shareholders' Meeting Rules, and other relevant laws, regulations, and normative documents, as well as the Company's Articles of Association.